Accessibility Menu
 
Proteome Sciences Plc logo

Proteome Sciences Plc

(LSE) PRM

Current Price$1.85
Market Cap$589.22M
Since IPO (1995)-99%
5 Year-74%
1 Year-39%
1 Month+6%

Proteome Sciences Plc Financials at a Glance

Market Cap

$589.22M

Revenue (TTM)

$8.64M

Net Income (TTM)

$6.47M

EPS (TTM)

$-1.04

P/E Ratio

-1.62

Dividend

$0.00

Beta (Volatility)

0.01 (Low)

Price

$1.85

Volume

600,786

Open

$1.68

Previous Close

$1.85

Daily Range

$1.56 - $1.85

52-Week Range

$1.20 - $4.40

PRM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Proteome Sciences Plc

Industry

Life Sciences Tools and Services

CEO

Mariola Söhngen, MD

Headquarters

Cobham, KT11 3EP, GB

PRM Financials

Key Financial Metrics (TTM)

Gross Margin

-27%

Operating Margin

-71%

Net Income Margin

-81%

Return on Equity

0%

Return on Capital

32%

Return on Assets

-37%

Earnings Yield

-61.73%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$589.22M

Shares Outstanding

350.73M

Volume

600.79K

Avg. Volume

346.44K

Financials (TTM)

Gross Profit

$1.01M

Operating Income

$2.67M

EBITDA

$1.74M

Operating Cash Flow

$46.00K

Capital Expenditure

$97.00K

Free Cash Flow

$143.00K

Cash & ST Invst.

$781.00K

Total Debt

$15.77M

Proteome Sciences Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.90M

+4.5%

Gross Profit

$917.00K

-664.2%

Gross Margin

-48.29%

N/A

Market Cap

$589.22M

N/A

Market Cap/Employee

$16.37M

N/A

Employees

36

N/A

Net Income

$921.00K

+50.6%

EBITDA

$532.00K

+57.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$14.99M

-30.9%

Accounts Receivable

$754.00K

-28.2%

Inventory

$537.00K

-35.8%

Long Term Debt

$824.00K

-49.5%

Short Term Debt

$14.95M

+26.2%

Return on Assets

-37.08%

N/A

Return on Invested Capital

32.06%

N/A

Free Cash Flow

$812.00K

+100.0%

Operating Cash Flow

$851.00K

+100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GDR.LGenedrive Plc
$0.95+2.70%
TRX.LTissue Regenix Group plc
$7.25+0.00%
CRTX.LCRISM Therapeutics Corporation
$12.75+0.00%
TCF.LTheracryf Plc
$0.22-2.22%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%

Questions About PRM

What is the current price of Proteome Sciences Plc?

Proteome Sciences Plc is trading at GBX 1.85 per share.

What is the 52-week range for Proteome Sciences Plc?

Over the past 52 weeks, Proteome Sciences Plc has traded between GBX 1.20 and GBX 4.40.

How much debt does Proteome Sciences Plc have?

As of the most recent reporting period, Proteome Sciences Plc reported total debt of $15.77M.

How much cash does Proteome Sciences Plc have on hand?

Proteome Sciences Plc reported $781,000 in cash and cash equivalents in its most recent financial results.

What is Proteome Sciences Plc’s dividend yield?

Proteome Sciences Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.